On 3/18/24, vTv Therapeutics Inc (NASDAQ: VTVT) stock enjoyed a major increase of 11.8%, closing at $20.12. However, trading volume in this advance was exceptionally low at 39% of normal. The stock has risen 38.4% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, VTVT is expected to be a major Value Eraser.
vTv Therapeutics is currently unrated.
Rating Review
The stock is currently unrated.